Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 20424220.
- Also identified by DOI 10.2337/dc09-2302 and PMC identifier 2909045.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate whether dietary phylloquinone and menaquinones intakes are related to risk of type 2 diabetes. We used data from a prospective cohort study in 38,094 Dutch men and women, aged 20-70 years. Dietary phylloquinone and menaquinones intakes were assessed using a validated food frequency questionnaire. Diabetes case patients were ascertained mainly via self-report and verified against medical records. During 10.3 years of follow-up, 918 incident cases of diabetes were documented. In a multivariate model adjusting for diabetes risk factors and dietary factors, phylloquinone intake tended to be associated (P = 0.08) with a reduced risk of type 2 diabetes with a hazard ratio (HR) of 0.81 (95% CI 0.66-0.99) for the highest versus the lowest quartile. For menaquinones intake, a linear, inverse association (P = 0.038) with risk of type 2 diabetes was observed with an HR of 0.93 (0.87-1.00) for each 10-microg increment in the multivariate model. This study shows that both phylloquinone and menaquinones intakes may be associated with a reduced risk of type 2 diabetes.
Medical subject headings
- Diabetes Mellitus, Type 2
- Vitamin K 1
- Vitamin K 2
- Vitamins